Accessibility settings

Published on in Vol 14 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/72435, first published .
Man with hands on temples looking stressed at laptop

A Smartphone-Based Ecological Momentary Intervention for Workplace Mental Health: Randomized Controlled Trial

A Smartphone-Based Ecological Momentary Intervention for Workplace Mental Health: Randomized Controlled Trial

1Department of Community Health and Behavioral Medicine, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China

2Wofoo Joseph Lee Consulting and Counselling Psychology Research Centre, Lingnan University, Tuen Mun, China (Hong Kong)

3Neurum Health, Central Hong Kong Island, China (Hong Kong)

4Department of Population Health and Policy, School of Health and Medical Sciences, City St. George’s, University of London, Cranmer Terrace, London, United Kingdom

Corresponding Author:

Meanne Chan, PhD


Background: Work-related stress has been widely associated with an increased risk of various mental disorders and poor mental well-being. The fast-growing mobile health services industry has provided new opportunities for workplace mental health.

Objective: This randomized controlled trial examined the effectiveness of Neurum (Neurum Limited), a smartphone-based intervention tool featuring ecological momentary assessments and interventions that aims to reduce workplace stress in real-time and real-world settings.

Methods: A total of 201 working adults were recruited for a 4-week smartphone-based intervention that incorporated cognitive behavioral therapy, mindfulness exercises, and self-regulation exercises delivered on Neurum. A simple randomization procedure was used. Participants in the intervention group were encouraged to log mood journals, complete mental health exercises, and provide user feedback whenever applicable. The key outcome was measured by the Depression, Anxiety, and Stress Scale-21 items (DASS-21; Cronbach α=0.87).

Results: The intervention group consisted of 102 participants, while the control group consisted of 99 participants. More participants dropped out from the intervention group (n=21) than from the control group (n=2; χ21=18.259; P<.001). The final sample consisted of 178 participants (male: 85/178, 47.8%; female: 93/178, 52.2%; mean age of 34.65, SD 7.67 y). Analyses revealed that after the 4-week intervention, the DASS-21 scores decreased in the intervention group (mean difference [MD]post-pre intervention=14.518) but increased in the control group (MDpost-pre intervention=3.319; F1,176=59.358, P<.001; η2=0.252). This effect was largely led by stress reduction (F1,176=64.679, P<.001; for the intervention group, MDpost-pre intervention=6.692, while for the control group, MDpost-pre intervention=2.000). On average, participants completed 6.27 (SD 9.4) exercises and provided 9.74 (SD 18.2) mood journal logs, with a daily engagement of 4.95 (SD 6.89) minutes. However, the associations between the changes in DASS-21 scores and the numbers of exercises or mood journal logs did not reach statistical significance.

Conclusions: This study primarily established the effectiveness of Neurum in alleviating depression, anxiety, and stress symptoms in noninstitutionalized working adults, with a satisfactory user retention rate. Despite potential health-related culture differences, Neurum contributed to evidence-based digital health in nonclinical settings for timely needs and general accessibility as an alternative to traditional, face-to-face, and high-cost mental health services. Future directions involving a personalized approach in online mental health services were discussed.

Trial Registration: Chinese Clinical Trial Registry ChiCTR2600131522; https://tinyurl.com/mpdrfdvx

JMIR Mhealth Uhealth 2026;14:e72435

doi:10.2196/72435

Keywords



Background

While the working population is the driving force of the global economy, common mental disorders (ie, depression and anxiety) alone have cost US $1 trillion each year due to the loss of productivity [1,2]. Pharmacotherapies, psychotherapies, or a combination of both are the primary approaches in managing the symptoms of common mental disorders [3-5]. However, suboptimal service use exists to hinder the influence of the mental health care system [6,7]. The poor mental health service use suggested an immense service gap that might not sufficiently or appropriately support the needs of individuals with mental health difficulties. Against this backdrop, it has become essential to further explore accessible, affordable, and effective alternatives to existing mental health care services for the working population.

Longitudinal studies have demonstrated that work-related stress—such as excessive workload, effort-reward imbalance, and low work social support—is associated with increased risks of depression and anxiety disorders and poor mental well-being [8-11]. Despite a large investment in mental health services and their significant effectiveness, the cost of maintaining these face-to-face interventions is high and often challenging, steering the research direction towards identifying low-cost, evidence-based strategies to optimize intervention cost-efficiency [12-18]. Worse yet, the COVID-19 pandemic has further threatened the mental health landscape of working adults by impacting individuals’ job security, chronic isolation, and uncertainty about the future, as well as adding constraints to traditional face-to-face intervention options [19]. Most of the existing interventions are limited in reaching out to those in need during a pandemic situation, increasing the risk and prevalence of mental ill health [19-22]. This limitation also applies to long-existing underuse issues of mental health services, especially in Asian countries [23,24]. For illustration, previous research in China revealed that only 24% of the participants who were diagnosed with moderate or severe mental health problems sought help from mental health professionals [25]. Reasons included issues such as health service accessibility and costs, as well as associated mental health stigmas. Therefore, mobile health (mHealth) seems a practical approach to improve the low rate of health-seeking behaviors given its advantages of being low cost, easily accessible, and stigma-free. Therefore, attention has increasingly shifted toward digital approaches as a feasible and scalable alternative.

A recent randomized controlled trial (RCT) showed that web-based mindfulness and cognitive behavioral training were efficacious in alleviating psychological distress among college students and young working adults [26]. Several meta-analyses suggested that web-, application-, and/or computer-based interventions were effective in alleviating depression, anxiety, and stress, though with undeniably concerning attrition rates ranging widely from 43% to 99% [27-31]. Taken together, these findings pointed out the effectiveness of internet-based psychological interventions while urging further refinement of their user retention especially for long-term benefits. In addition to internet-based interventions, mHealth platforms that adopt mobile and wireless devices to improve health care also appear promising [32]. Not only has mHealth long been used in physical health care, such as for diabetes management, infectious disease management, and immunization management, increasing application of mHealth to mental health also has emerged, ranging from alcohol and substance use assessment to low-intensity interventions for mental disorders [33-38]. Despite the enlightening trend, less than 5% of the mHealth platforms underwent peer-reviewed research, while the majority of these were conducted in western countries [39,40]. Peer-reviewed, demographically diverse research awaits attention.

Advancements, availability, and affordability of mobile technology have given rise to ecological momentary assessment (EMA), which allows individuals to report experiences and behaviors in everyday lives and in naturalistic settings [41,42]. The rationale for using EMA rests upon 3 major advantages including reducing retrospective recall, improving generalizability and ecological validity, and enabling the exploration of temporal relationships among variables. Similarly, ecological momentary intervention (EMI) refers to the delivery of intervention while individuals are naturally engaged in their everyday lives [43,44]. Emerging evidence suggested the effectiveness of EMI in alleviating anxiety and stress and treating a variety of health behaviors and psychological symptoms [44,45]. However, RCTs of EMA and EMI in mental health promotion remained scarce [45]—and their application in workplace mental health services is even more limited. This is noteworthy given that both approaches could offer unique benefits to working adults, as they deliver mental health care services free from temporal and spatial constraints. Therefore, this gap underscores the need for rigorous investigation of EMA- and EMI-based mHealth tools, particularly in workplace populations and non-Western contexts.

Objectives

To address this gap, this preregistered RCT was designed to evaluate the effectiveness of a smartphone-based intervention (ie, the Neurum app; Neurum Limited) that leverages both EMA and EMI in reducing workplace stress [46]. Study hypotheses and corresponding analytical schemes were preregistered in September 2020 (registration reference: osf.io/z829u) before the data collection was finished. No statistical analysis was done before the preregistration or the completion of data collection. Specifically, it was hypothesized that participants who received intervention through the Neurum app would display better workplace stress management and mental health improvement as reflected by the reduction in depression, anxiety, and/or stress symptoms. The design, conduct, and reporting of this study followed the CONSORT-EHEALTH (Consolidated Standards of Reporting Trials of Electronic and Mobile Health Applications and Online Telehealth) guidelines (Checklist 1).


Participants

This study was a 2 (between: intervention vs waitlist control groups) × 2 (within: premeasures vs postmeasures) mixed factorial design. A priori power analysis using F test family (repeated measures, between factors) in G*Power was conducted [47]. Assuming a small effect size (ie, f=0.25) and a high correlation between premeasures and postmeasures of the outcome variable (ie, r=.85), with an α level of .05, a total number of 196 participants was needed to achieve a power of 0.80. Assuming an attrition rate of 25%, a sample of 262 participants was determined prior to data collection.

Participant recruitment started in September 2019, Hong Kong SAR. Advertisements were posted on the company websites and populated through themed webinars and offline workshops to reach local working adults. However, due to local social unrest and the COVID-19 pandemic, few signed up within the planned 1-month recruitment period. Therefore, under all authors’ and the funding agency’s approval, the recruitment process was prolonged until the deemed sample size would be achieved. The recruitment process lasted for over a year and was finally terminated by the end of October 2020, when nearly no more participants signed up within 30 days. To maximize the sample size, those who signed up and passed the screening immediately underwent the intervention process. However, no data analysis was conducted before the end of the study. In total, 201 working adults were recruited from a selected list of local companies, who were first directed to an online survey with screening questions, in which they reported their demographic and mental health information. A research assistant who remained unaware of the study design was in charge of the eligibility screening. Specifically, participants were eligible if they (1) were aged 18 years or older at sample recruitment, (2) had access to the internet and a smartphone, and (3) were not diagnosed with major mental disorders. Exclusion criteria included (1) mental illness diagnosis history, (2) current reception of professional mental health services, or (3) current use of psychotropic medication.

Ethical Considerations

Ethical approval was obtained from the Subcommittee on Research Ethics and Safety of the Research Committee of Lingnan University (reference: EC047/2021). All procedures contributing to this work complied with the ethical standards of the relevant national and institutional committees on human study. Informed consent was obtained via electronic signatures indicating the awareness of the study procedure, potential risks and benefits, data confidentiality, and the right to quit the study at any time. Data were encrypted and stored in a financial-sector security level server and deidentified before statistical analysis. No incentives or compensations were provided.

Procedure

All procedures were delivered via Neurum. Included participants first completed the preintervention assessment, and then they were randomly allocated at a 1:1 ratio to the two groups via a computer algorithm of simple randomization. Specifically, a numerical value between 0 and 1 was assigned to each participant. Those who received a value smaller than 0.5 were assigned to the control group; otherwise, participants were assigned to the intervention group. Double blindness was achieved such that a research assistant who remained unaware of the study design was in charge of the participant assignment, while participants received a unique study ID in a singular format that revealed no group information, and therefore, remained unaware of the grouping. Then, participants in the intervention group received EMA and EMI via Neurum for 4 weeks, while those in the waitlist control group were offered the intervention after the RCT was completed. Finally, all participants completed a postintervention assessment with debrief at the end of the trial (ie, after the designated 4-week intervention [or control] duration).

Intervention

Neurum is a smartphone app that comprises self-managed mental health modules designed in various combinations of (1) featured techniques, namely cognitive behavioral therapy, mindfulness exercises, and self-regulation skills with (2) various session formats including informational (ie, psychoeducation), evaluative (ie, assessment), and applicable (ie, exercise), aiming at (3) tangible goals in alignment with the biopsychosocial model, namely the improvement and maintenance of biological, psychological, and social health. See Table 1 for a summary of the different components and the rationale.

Table 1. Neurum intervention framework and module examples.
Example moduleFeatured techniqueFormat
PsychoeducationAssessmentExercise
Biological
 AcupressureSelf-regulation
 Sleep qualityMindfulness
Psychological
 Focus timerSelf-regulation
 Managing stressCognitive-behavioral therapy
 Sustaining happinessMindfulness
Social
 Workplace boundariesSelf-regulation

Neurum is designed with an instant messenger–like user interface where users interact with the virtual app assistant in a conversation format. The palatability of the dialogues was ensured by using layman and local terms in either English or Chinese. The app content was developed with standard app development iterations that involved digitizing of modules based on previously validated mental health education and behavioral changing paradigms, and then user testing with an A/B test method to compare the performance of 2 versions of content. This study describes the foundation of the app, which matches users to an EMI based on information from their EMA via a combination of supervised learning models, but future iterations of Neurum involved personalization of EMI modules based on nuances from EMA, session feedback, and other baseline user data via a more complex deep learning algorithm. As part of the safeguarding protocol, a referral mechanism is established, such that users who score past a certain threshold in their levels of psychological distress are automatically referred to crisis management protocol, which involves the algorithm providing the user with immediate support via distress reduction modules, crisis hotlines, and face-to-face care delivered by a licensed, on-board clinical psychologist. No adverse events were reported during the study.

EMA is delivered such that users are invited to complete a mood journal on Neurum to log their instant emotions, thoughts, and behaviors relevant to workplace stress as well as other psychological distress whenever they feel in need. Users evaluate their general feelings along a negative-to-positive continuum, specify a specific experience they would like to work on, and then identify one or more associated stressors. EMI is delivered such that, upon EMA logs, Neurum would make a recommendation to relevant, evidence-based intervention modules based on an immediate matching of the current demand and available training tools using a self-developed, built-in supervised machine learning algorithm. User feedback is further collected after each training session, which also informs the algorithm. A daily summary of the reported mood experiences and taken exercises was provided for self-monitoring of workplace stress and management performance. See Figure 1 for the overview of Neurum’s EMA or EMI workflow.

Figure 1. Illustration of ecological momentary assessment (EMA) and ecological momentary intervention (EMI) workflow on the Neurum (Neurum Limited) app.

Measures

Depression, Anxiety, and Stress

Key outcomes, namely the intervention effectiveness, were evaluated by comparing the prescores and postscores of the Depression, Anxiety, and Stress Scale-21 items (DASS-21) [48]. Participants rated the extent to which they experienced depression, anxiety, and stress symptoms (7 items for each dimension; eg, “I was worried about situations in which I might panic”) on a 4-point scale (0=“Did not apply to me at all” to 3=“Applied to me very much or most of the time”). Sum scores were computed for the 3 subdimensions as well as the total scores such that higher scores reflected more severe symptoms. The adopted Chinese version of the DASS-21 exhibited satisfactory psychometric properties (Cronbach α ≥0.80) [49]. Cronbach α in this study was 0.87.

Mood Journal

Participants in the intervention group were invited to report, every time they logged in, on (1) how they were feeling in general; (2) whether they were feeling any specific emotion, such as happy or disappointed; and if yes, (3) the source of emotion such as family, work, or friends.

User Activity

User activity was measured by the number of mood journals completed and exercise sessions taken, as well as daily user engagement (in min).

Other Measures

At baseline, participants provided demographic information including sex, age, and marital status.

Analytical Scheme

To examine the intervention effect, pre– and post–DASS-21 scores of the intervention and control groups were submitted to a 2 (between: intervention vs control groups) × 2 (within: premeasures vs postmeasures) mixed ANOVA. Additional analyses included categorical demographic characteristics (namely sex, education, and marital status; Table 2) as control variables. A supplementary set of mixed ANOVA was conducted to compare intensity level changes for each symptom. Finally, 2 multiple linear regressions with a number of mood journals and exercise sessions completed were conducted to explore any dose-response effect.

Table 2. Demographic characteristics and baseline Depression, Anxiety, and Stress Scale-21 items (DASS-21) scores for each group.
CharacteristicsControl group (n=97)Intervention group (n=81)
Age (y), mean (SD)34.65 (7.67)36.43 (12.84)
Sex, n (%)
Female51 (53)42 (52)
Male46 (47)39 (48)
Education, n (%)
High school5 (5)8 (10)
Bachelor’s degree64 (66)48 (59)
Master’s degree0 (0)18 (22)
PhD or above6 (6)3 (4)
Prefer not to tell22 (23)4 (5)
Marital status, n (%)
Single54 (56)40 (49)
Married33 (34)38 (47)
Divorced7 (7)2 (2)
Separated3 (3)0 (0)
Prefer not to tell0 (0)1 (1)

Sample Characteristics

Figure 2 shows the participant flow diagram. Demographic characteristics are summarized in Table 2. The majority of study participants were females, had bachelor’s degrees, and were single in terms of marital status. Though the overall attrition rate was low (23/201, 11.4%), there were significantly more participants dropped from the intervention group (n=21) than from the control group (n=2; χ21=18.259; P<.001), resulting in 81 participants in the intervention group and 97 in the control group. Considering the intensive EMA or EMI procedures, the differential attrition rates between the 2 groups were not surprising. More importantly, the final sample consisted of 178 working adults and was still sufficient in statistical power.

Figure 2. Participant flow diagram.

User Activity

On average, participants in the intervention group provided 9.74 (SD 18.2; maximum=130) mood journals and completed 6.27 (SD 9.4; maximum=51) exercises, while neither was correlated to preintervention DASS-21 scores (|r|s ≤.156; Ps≥.16), and neither was predicted by sex (t79s≤0.744; Ps≥.46), education level (F3, 73s≤1.947; Ps≥.13), or marital status (F2, 77s≤2.002, Ps≥.14). Daily user engagement on average was 4.95 (SD 6.89; maximum=30) minutes, which was positively correlated with preintervention stress scores (r=0.233; P=.002) and total DASS-21 scores (r=0.175; P=.02), but was not predicted by sex (t78=0.791; P=.22), educational level (F3, 73=1.595; P=.20), or marital status (F2, 76=0.100; P=.91).

Intervention Effects

Preintervention and postintervention DASS-21 scores, as well as the mean differences, are presented in Table 3. Mixed ANOVAs were applied to compare the pre– and post–DASS-21 total and subscale scores between groups (Table 4). For the total score, equal variance between groups was satisfied (Levene statistics ≤2.127; P≥.15). Results revealed that there was no significant difference between the intervention (mean difference [MD]=21.990) and the control (MD=21.852) groups; but as expected, there was a significant postintervention decrease (MDpreintervention=24.721 and MDpostintervention=19.121). More importantly, the above effects were quantified by a significant, large-effect size interaction between time and group (Figure 3A) such that the DASS-21 total scores decreased for the intervention group (MDpreintervention=29.111 and MDpostintervention=14.593) but increased for the control group (MDpreintervention=20.330 and MDpostintervention=23.649). Similar patterns (Figure 3B-D) were found for the three symptoms such that average scores notably decreased for the intervention group but slightly increased for the control group (F1, 176s≥22.689, Ps<.001), with the strongest effect observed in the stress symptom.

Table 3. Preintervention and postintervention scores and mean differences between groups (ncontrol=97 and nintervention=81).
VariablePreintervention, mean (SD)Postintervention, mean (SD)Mean differencea
ControlInterventionControlInterventionControlIntervention
Depression6.866 (6.843)8.938 (7.417)7.588 (7.071)4.691 (7.015)0.722−4.247
Anxiety5.361 (6.289)7.185 (5.812)5.959 (5.752)3.605 (4.398)0.598−3.580
Stress8.103 (7.248)12.988 (7.76)10.103 (7.796)6.296 (6.520)2.000−6.692
Total20.33 (16.283)29.111 (17.975)23.649 (16.857)14.593 (15.174)3.319−14.518

aMean differences are computed as postintervention minus preintervention scores.

Table 4. Mixed ANOVAs of preintervention and postintervention Depression, Anxiety, and Stress Scale-21 items (DASS-21) scores between groups (ncontrol=97 and nintervention=81).
OutcomeF test (df)P valueη2
Total
Between
 Group0.004 (1, 176).950.000
Within
 Time23.396 (1, 176)<.0010.117
 Time × group59.358 (1, 176)<.0010.252
Depression
Between
 Group0.197 (1, 176).660.001
Within
 Time11.422 (1, 176).0010.061
 Time × group22.689 (1, 176)<.0010.114
Anxiety
Between
 Group0.122 (1, 176).730.001
Within
 Time15.182 (1, 176)<.0010.079
 Time × group29.800 (1, 176)<.0010.145
Stress
Between
 Group0.310 (1, 176).580.002
Within
 Time18.844 (1, 176)<.0010.097
 Time × group64.679 (1, 176)<.0010.269
Figure 3. Preintervention and postintervention Depression, Anxiety, and Stress Scale-21 items (DASS-21) results including (A) total score and (B) depression, (C) anxiety, and (D) stress subdimensional scores between intervention and control groups. Error bars represent 95% CIs.

Supplementary Analyses

A set of supplementary models found similar patterns controlling for sex, education, and marital status (for condition effects, F1, 146s≤1.601, Ps≥.21, η2≤0.011; for time effects, F1, 146s≥2.933, Ps≤.09, η2≥0.020; for interaction effects F1, 146s≥19.286, Ps≤.001, η2≥0.117), suggesting that the above intervention effects held after controlling for these demographic covariates. Another set of supplementary models (Table 5) found similar patterns using DASS-21 symptom intensity levels as the outcome variables. Change(s) of these intensity levels suggested that the control group ascended while the intervention group descended in symptom severity (χ22s≥ 8.605; Ps≤.02). Finally, and surprisingly, a final set of supplementary models (Table 6) using multiple linear regressions revealed that none of the exercise session number, mood journal number, or average daily engagement predicted the postintervention DASS-21 scores.

Table 5. Intensity level changes between groups (ncontrol=97 and nintervention=81)a.
Intensity level changeChi-square (df)P value
Worsen, n (%)No change, n (%)Improved, n (%)
Depression
 Control17 (18)64 (66)16 (16)8.605 (2).02
 Intervention9 (11)44 (54)28 (35)
Anxiety
 Control21 (22)67 (69)9 (9)27.581 (2)<.001
 Intervention5 (6)43 (53)33 (41)
Stress
 Control19 (20)72 (74)6 (6)23.404 (2)<.001
 Intervention4 (5)52 (64)25 (31)

aCell values in each intensity change category are counts of participants.

Table 6. User activity and postintervention Depression, Anxiety, and Stress Scale-21 items (DASS-21) scores for the intervention group (n=81).
BSEP value95% CI
Total scorea
 Model 1
 Baseline level0.2200.092.020.037 to 0.403
 Model 2
 Baseline level0.2240.093.020.038 to 0.410
 Exercise session−0.0730.194.710.459 to 0.313
 Mood journal0.1200.099.23−0.077 to 0.318
 Daily engagement0.2400.253.35−0.263 to 0.744
Depressionb
 Model 1
 Baseline level0.2860.102.0060.083 to 0.489
 Model 2
 Baseline level0.2960.105.0060.086 to 0.505
 Exercise session0.0010.088.99−0.175 to 0.177
 Mood journal0.0270.046.59−0.064 to 0.119
 Daily engagement0.0290.117.80−0.204 to 0.262
Anxietyc
 Model 1
 Baseline level0.2410.081.0040.080 to 0.403
 Model 2
 Baseline level0.2280.083.0080.062 to 0.394
 Exercise session−0.0330.056.55−0.144 to 0.078
 Mood journal0.0180.029.52−0.038 to 0.075
 Daily engagement0.0860.073.25−0.060 to 0.232
Stressd
 Model 1
 Baseline level0.2010.092.030.018 to 0.385
 Model 2
 Baseline level0.2000.092.030.018 to 0.383
 Exercise session−0.0350.082.67−0.199 to 0.128
 Mood journal0.0770.042.08−0.007 to 0.160
 Daily engagement0.1290.108.23−0.085 to 0.343

aFor model 1, adjusted R2=0.068, F1,78=5.731, P=.02; and for model 2, adjusted R2=0.097, F1,72=0.777, P=.51.

bFor model 1, adjusted R2=0.080, F1,78=7.855, P=.006; and for model 2, adjusted R2=0.049, F1,72=0.162, P=.92.

cFor model 1, adjusted R2=0.091, F1,78=8.866, P=.004; and for model 2, adjusted R2=0.076, F1,72=0.601, P=.62.

dFor model 1, adjusted R2=0.045, F1,78=4.762, P=.03; and for model 2, adjusted R2=0.067, F1,72=1.593, P=.20.


Overview

This RCT examined the effectiveness of a smartphone-based EMA or EMI mental health care services delivered by the Neurum app in mitigating workplace stress and improving mental health for working adults in Hong Kong SAR, China. Consistent with the hypotheses, results demonstrated that the approach was effective in reducing psychological distress after 4 weeks of intervention, suggesting that the EMA or EMI approach via the Neurum app could support working adults’ stress management in real time and in naturalistic settings.

Principal Findings

This study demonstrated the effectiveness of integrating EMA or EMI techniques with supervised machine learning algorithms in digital mental health care for a nonclinical population. The findings were broadly compatible with previous studies supporting the effectiveness of mHealth tools in reducing general anxiety, various stress, and depression symptoms [45,50]. Importantly, the effectiveness of Neurum was supported not only by the continuous reduction of psychological symptoms but also by the shifts in symptom intensity levels, suggesting potential use that extends from non–clinical contexts into early-stage clinical applications. One well-known advantage of the ecological momentary approach is its ability to minimize retrospective bias and enhance event trigger monitoring. Previous research has highlighted the promise of such digital phenotyping for routine clinical assessment, particularly for early onset or relapse [51]. Our observed changes in categorical symptom intensity levels further supported this clinical relevance, indicating that symptom improvement was substantial enough to cross the established cutoff thresholds. Because categorical severity shifts could provide a more interpretable indicator of treatment effectiveness than numerical score changes alone, these findings underscore the potential of EMA or EMI-based mHealth tools for early identification, timely intervention, and preventative health care in mental health. Additionally, previous meta-analyses research revealed that multicomponent intervention was tentatively more effective than single-component ones (eg, with cognitive behavioral therapy alone), and that patient preferences for specific intervention components played a pivotal role in treatment outcomes [52,53]. In response to these challenges, the intervention delivered in Neurum integrated multiple modules in various delivery formats for actionable outcomes, enabling participants to decide whether and which exercises to engage in upon each log-in. This inclusive design undoubtedly promoted user retention and engagement and maximized the alignment between individual needs and intervention content, a pattern supported by our user activity data. Taken together, these novel findings highlighted the importance of developing scalable, personalized mHealth tools as accessible, affordable, and flexible alternatives to face-to-face mental health care services.

There were several important issues in the interpretation of results. First of all, more participants dropped out of the intervention group than from the control group. It is noteworthy that the overall dropout did not exceed the predetermined attrition rate for power analysis. It is also noteworthy that the current attrition rate (ie, 11.4%) was smaller than those reported in previous studies (eg, about 26% for cognitive behavioral therapy and about 19% for mindfulness-based traditional interventions, or widely ranging from 43% to 99% for general digital health interventions [27-31,54-56]). Despite this, authors speculated the presence of some exposure effects particularly for the intervention group. Specifically, EMA or EMI required participants to review their mood swings on a daily basis, to exert efforts in managing especially those negative daily experiences, and to review their own performances on the taken exercises. Compared to those assigned to the control groups, these tasks might make the mental health issues more evident than they used to be (namely, before participating in this study) for the intervention group, possibly resulting in a withdrawal from treatment effect frequently observed in traditional psychotherapies [57]. Regrettably, the current design did not include relevant measures to test this speculation. However, to improve its future retention, the intervention could benefit from including methods to cope with the aforementioned exposure effect in the onboarding stage. Meanwhile, a personalized approach that maps personal needs with module recommendations can also improve user retention and performance. In fact, future iterations of Neurum have involved personalization of EMI modules based on nuances from EMA, session feedback, and other baseline user data via a more complex deep learning algorithm. Second, the results somewhat failed to support the association between the number of completed exercises or mood journals with DASS-21 score changes. In other words, the underlying dose-response effect remained unclear. One possible reason was that participants were only encouraged but not forced to report their daily mood journals or to take exercises. Granted that it strategically maximized participants’ acceptance and adherence [58], it undeniably resulted in the limitation of a relatively low daily response rate, and subsequently, the lack of statistical power to reveal the targeted dose-response effect, if any. Therefore, future studies might consider assigning a compulsory number of daily responses to unveil potential underlying mechanisms. Despite this, the current intervention effects could be a result of the improved awareness of one’s own mental health status and consequently improved proactive mental health management effort, or an effect generalized from in-app exercises to realistic life scenarios.

This study also contributes to the relatively nascent field of mHealth research, typically the application of EMA or EMI, in Asian countries [40]. Though with a rapid growth and a wide application, empirical supports of EMA or EMI for mental health were mostly from the United States and European countries (eg, Germany and the Netherlands), with the only exception being a study involving Chinese participants with mild-moderate depression [59-61]. However, western-based mHealth apps were not necessarily applicable to eastern ones [62]. The common mHealth apps in Asian contexts have remained in psychoeducation, counseling services, and self-assessment tools [40,63], while this study expanded them by leveraging the more intense EMA or EMI approach. Furthermore, Neurum takes health equity and cultural adaptivity into consideration by offering multiple language versions (viz, both traditional and simplified Chinese, English, Filipino, and Hindi) to serve local people with different cultural backgrounds. Though ethnicity was not collected in this investigation, the recruitment process was indeed carried out in international enterprises in Hong Kong, SAR. Finally, this study expanded the use of EMA or EMI beyond clinical settings to community populations, which broadened the spectrum of the recipients of such digital health care services. While some digital health tools can be used by patient populations to clinically reduce their depression and/or anxiety, this must be differentiated from digital health tools that are meant to reduce these symptoms in a non–clinical population. The demonstrated effectiveness of Neurum is similar to other well-being and mindfulness apps, such as Calm and Headspace [64-66]. Furthermore, the function of these digital health platforms and the reduction in mental health symptoms are similar to those of other non–clinical interventions like yoga [67]. The wellness technology industry has been growing exponentially with app-based options that are not designed to replace clinical treatment altogether, but to offer complementary early intervention tools, or as alternative options for those that struggle to access in-person care. Relatedly, Neurum essentially represents a shift from disease-centered to health-centered, proactive mental health approach. EMA or EMI, combined with diverse delivery formats (namely, informational, evaluative, and practical), comprehensively supports a proactive mental health management system by addressing foundational mental health literacy, enabling timely monitoring, fostering essential skills, and promoting sustained actions. Such a shift of medical models for mental health corroborates the notion of prevention over treatment, as globally advocated by many governmental and regional health policies [68-71].

Limitations

This study has several limitations. First, despite the authors’ effort to recruit participants and maintain their engagement during the local social unrest and the COVID-19 pandemic, the final sample size was still slightly smaller than expected. However, the effect size of mixed ANOVA was large, supporting the effectiveness of the intervention. Second, even though Neurum was designed with multiple languages, ethnicity information was not collected, which precluded the possibility of examining cultural differences, if any. Factors such as mental health beliefs, perceptions, and literacy should merit future research attention to improve the generalizability of Neurum in other cultures [72,73]. Third, while the attrition rate of the current study was low, local RCTs on web-based and application-based mental health programs suggested that personalized feedback might mitigate the high attrition rates typically in internet-based programs [26,74]. Indeed, several lines of evidence demonstrated the benefits of personalized intervention including better intervention outcomes, stronger subject adherence, and more persuasive feedback, in both physical and mental health domains [62,75-78]. As such, Neurum could be further advanced by incorporating the personalized intervention approach based on computational algorithms of the EMA or EMI data. Finally, the results of this study did not reveal a dose-response relationship between the reductions in psychological symptoms and the number of EMI sessions completed. A requirement of minimum sessions in the future can help examine the potential dose-response effect and better understand the intervention’s effectiveness.

Conclusions

In sum, this RCT supported that Neurum, a new mHealth intervention that coupled the ecological momentary approach with supervised machine learning algorithms, could effectively reduce workplace stress and psychological distress in working adults. Beyond establishing its efficacy, the findings also highlight the potential of day-to-day, context-sensitive data to deepen the understanding of how EMA or EMI functions within digital psychological interventions. By introducing inclusive design and diverse user groups, this work further underscores the importance of equity and cultural relevance in the next generation of digital mental health care. Together, these insights highlight the promise of adaptive, data-driven mHealth tools in expanding the access to effective psychological support across different populations and in real-time and real-world settings.

Acknowledgments

The authors would like to express their sincere appreciation for the participants’ devotion. No generative artificial intelligence was used in any portion of the manuscript writing.

Funding

This study was funded by the Research Grants Council of Hong Kong, SAR, to MC (reference: 17601421).

Data Availability

Anonymized data would be available upon appropriate requests towards the corresponding author.

Authors' Contributions

Conceptualization: SL, ML, MC

Data curation: CYCL, LHLL

Formal analysis: SL

Funding acquisition: MC

Investigation: ML, MC

Methodology: SL, ML, MC

Project administration: CYCL, LHLL

Resources: ML, MC

Software: ML

Supervision: MC

Validation: SL

Visualization: SL

Writing – original draft: CYCL, LHLL, SL

Writing – review & editing: SL, MC

Conflicts of Interest

None declared.

Editorial Notice

This randomized study was only retrospectively registered. The editor granted an exception from ICMJE rules mandating prospective registration of randomized trials, because the risk of bias appears low with a record of the protocol available publicly prior to the end of enrolment. However, readers are advised to carefully assess the validity of any potential explicit or implicit claims related to primary outcomes or effectiveness, as retrospective registration does not prevent authors from changing their outcome measures retrospectively.

Checklist 1

CONSORT-EHEALTH checklist.

PDF File, 123 KB

  1. Dewa CS, Lesage A, Goering P, Craveen M. Nature and prevalence of mental illness in the workplace. Healthc Pap. 2004;5(2):12-25. [CrossRef] [Medline]
  2. The Lancet Global Health. Mental health matters. Lancet Glob Health. Nov 2020;8(11):e1352. [CrossRef] [Medline]
  3. Strawn JR, Geracioti L, Rajdev N, Clemenza K, Levine A. Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review. Expert Opin Pharmacother. Jul 2018;19(10):1057-1070. [CrossRef] [Medline]
  4. Zhang A, Franklin C, Jing S, et al. The effectiveness of four empirically supported psychotherapies for primary care depression and anxiety: a systematic review and meta-analysis. J Affect Disord. Feb 15, 2019;245:1168-1186. [CrossRef] [Medline]
  5. Guidi J, Fava GA. Sequential combination of pharmacotherapy and psychotherapy in major depressive disorder: a systematic review and meta-analysis. JAMA Psychiatry. Mar 1, 2021;78(3):261-269. [CrossRef] [Medline]
  6. Schnyder N, Panczak R, Groth N, Schultze-Lutter F. Association between mental health–related stigma and active help–seeking: systematic review and meta-analysis. Br J Psychiatry. Apr 2017;210(4):261-268. [CrossRef] [Medline]
  7. Mackenzie CS, Gekoski WL, Knox VJ. Age, gender, and the underutilization of mental health services: the influence of help-seeking attitudes. Aging Ment Health. Nov 2006;10(6):574-582. [CrossRef] [Medline]
  8. Melchior M, Caspi A, Milne BJ, Danese A, Poulton R, Moffitt TE. Work stress precipitates depression and anxiety in young, working women and men. Psychol Med. Aug 2007;37(8):1119-1129. [CrossRef] [Medline]
  9. Grebner S, Semmer NK, Elfering A. Working conditions and three types of well-being: a longitudinal study with self-report and rating data. J Occup Health Psychol. Jan 2005;10(1):31-43. [CrossRef] [Medline]
  10. Law R, Clow A. Stress, the cortisol awakening response and cognitive function. Int Rev Neurobiol. 2020;150:187-217. [CrossRef] [Medline]
  11. Milner A, Krnjacki L, LaMontagne AD. Psychosocial job quality and mental health among young workers: a fixed-effects regression analysis using 13 waves of annual data. Scand J Work Environ Health. Jan 1, 2017;43(1):50-58. [CrossRef] [Medline]
  12. Ogden T, Hagen KA. Adolescent Mental Health: Prevention and Intervention. 2nd ed. Routledge; 2018. [CrossRef]
  13. Virgili M. Mindfulness-based interventions reduce psychological distress in working adults: a meta-analysis of intervention studies. Mindfulness. Apr 2015;6(2):326-337. [CrossRef]
  14. Kieling C, Baker-Henningham H, Belfer M, et al. Child and adolescent mental health worldwide: evidence for action. Lancet. Oct 22, 2011;378(9801):1515-1525. [CrossRef] [Medline]
  15. Corbière M, Shen J, Rouleau M, Dewa CS. A systematic review of preventive interventions regarding mental health issues in organizations. Work. 2009;33(1):81-116. [CrossRef] [Medline]
  16. Knapp M, Wong G. Economics and mental health: the current scenario. World Psychiatry. Feb 2020;19(1):3-14. [CrossRef] [Medline]
  17. Aknin LB, De Neve JE, Dunn EW, et al. Mental health during the first year of the COVID-19 pandemic: a review and recommendations for moving forward. Perspect Psychol Sci. Jul 2022;17(4):915-936. [CrossRef] [Medline]
  18. Fusar-Poli P, Correll CU, Arango C, Berk M, Patel V, Ioannidis JPA. Preventive psychiatry: a blueprint for improving the mental health of young people. World Psychiatry. Jun 2021;20(2):200-221. [CrossRef] [Medline]
  19. Giorgi G, Lecca LI, Alessio F, et al. COVID-19-related mental health effects in the workplace: a narrative review. Int J Environ Res Public Health. Oct 27, 2020;17(21):7857. [CrossRef] [Medline]
  20. Ratheesh A, Alvarez-Jimenez M. The future of digital mental health in the post-pandemic world: evidence-based, blended, responsive and implementable. Aust N Z J Psychiatry. Feb 2022;56(2):107-109. [CrossRef] [Medline]
  21. Talevi D, Socci V, Carai M, et al. Mental health outcomes of the COVID-19 pandemic. Riv Psichiatr. 2020;55(3):137-144. [CrossRef] [Medline]
  22. Hossain MM, Tasnim S, Sultana A, et al. Epidemiology of mental health problems in COVID-19: a review. F1000Res. 2020;9:636. [CrossRef] [Medline]
  23. Shi W, Shen Z, Wang S, Hall BJ. Barriers to professional mental health help-seeking among Chinese adults: a systematic review. Front Psychiatry. 2020;11:442. [CrossRef] [Medline]
  24. Wang PS, Aguilar-Gaxiola S, Alonso J, et al. Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet. Sep 8, 2007;370(9590):841-850. [CrossRef] [Medline]
  25. Phillips MR, Zhang J, Shi Q, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey. Lancet. Jun 13, 2009;373(9680):2041-2053. [CrossRef] [Medline]
  26. Mak WW, Chio FH, Chan AT, Lui WW, Wu EK. The efficacy of internet-based mindfulness training and cognitive-behavioral training with telephone support in the enhancement of mental health among college students and young working adults: randomized controlled trial. J Med Internet Res. Mar 22, 2017;19(3):e84. [CrossRef] [Medline]
  27. Reger MA, Gahm GA. A meta-analysis of the effects of internet- and computer-based cognitive-behavioral treatments for anxiety. J Clin Psychol. Jan 2009;65(1):53-75. [CrossRef] [Medline]
  28. Spek V, Cuijpers P, Nyklícek I, Riper H, Keyzer J, Pop V. Internet-based cognitive behaviour therapy for symptoms of depression and anxiety: a meta-analysis. Psychol Med. Mar 2007;37(3):319-328. [CrossRef] [Medline]
  29. Zhang Y, Xue J, Huang Y. A meta-analysis: Internet mindfulness-based interventions for stress management in the general population. Medicine. 2020;99(28):e20493. [CrossRef]
  30. Christensen H, Griffiths KM, Farrer L. Adherence in internet interventions for anxiety and depression. J Med Internet Res. Apr 24, 2009;11(2):e13. [CrossRef] [Medline]
  31. Christensen H, Griffiths KM, Mackinnon AJ, Brittliffe K. Online randomized controlled trial of brief and full cognitive behaviour therapy for depression. Psychol Med. Dec 2006;36(12):1737-1746. [CrossRef] [Medline]
  32. Adibi S, editor. Mobile Health: A Technology Road Map. Vol 5. Springer Cham; 2015. ISBN: 978-3-319-12817-7
  33. Ciemins E, Coon P, Sorli C. An analysis of data management tools for diabetes self-management: can smart phone technology keep up? J Diabetes Sci Technol. Jul 1, 2010;4(4):958-960. [CrossRef] [Medline]
  34. Oehler RL, Smith K, Toney JF. Infectious diseases resources for the iPhone. Clin Infect Dis. May 1, 2010;50(9):1268-1274. [CrossRef] [Medline]
  35. Kaewkungwal J, Singhasivanon P, Khamsiriwatchara A, Sawang S, Meankaew P, Wechsart A. Application of smart phone in “Better Border Healthcare Program”: a module for mother and child care. BMC Med Inform Decis Mak. Nov 3, 2010;10:69. [CrossRef] [Medline]
  36. Bakker D, Kazantzis N, Rickwood D, Rickard N. A randomized controlled trial of three smartphone apps for enhancing public mental health. Behav Res Ther. Oct 2018;109:75-83. [CrossRef] [Medline]
  37. Depp CA, Mausbach B, Granholm E, et al. Mobile interventions for severe mental illness: design and preliminary data from three approaches. J Nerv Ment Dis. Oct 2010;198(10):715-721. [CrossRef] [Medline]
  38. Bernhardt JM, Usdan S, Mays D, Martin R, Cremeens J, Arriola KJ. Alcohol assessment among college students using wireless mobile technology. J Stud Alcohol Drugs. Sep 2009;70(5):771-775. [CrossRef] [Medline]
  39. Lecomte T, Potvin S, Corbière M, et al. Mobile apps for mental health issues: meta-review of meta-analyses. JMIR mHealth uHealth. May 29, 2020;8(5):e17458. [CrossRef] [Medline]
  40. Li H, Lewis C, Chi H, Singleton G, Williams N. Mobile health applications for mental illnesses: an Asian context. Asian J Psychiatr. Dec 2020;54:102209. [CrossRef] [Medline]
  41. Myin-Germeys I, Kasanova Z, Vaessen T, et al. Experience sampling methodology in mental health research: new insights and technical developments. World Psychiatry. Jun 2018;17(2):123-132. [CrossRef] [Medline]
  42. Shiffman S, Stone AA, Hufford MR. Ecological momentary assessment. Annu Rev Clin Psychol. 2008;4:1-32. [CrossRef] [Medline]
  43. Smyth JM, Stone AA. Ecological momentary assessment research in behavioral medicine. J Happiness Stud. Mar 2003;4(1):35-52. [CrossRef]
  44. Heron KE, Smyth JM. Ecological momentary interventions: incorporating mobile technology into psychosocial and health behaviour treatments. Br J Health Psychol. Feb 2010;15(Pt 1):1-39. [CrossRef] [Medline]
  45. Loo Gee B, Griffiths KM, Gulliver A. Effectiveness of mobile technologies delivering Ecological Momentary Interventions for stress and anxiety: a systematic review. J Am Med Inform Assoc. Jan 2016;23(1):221-229. [CrossRef] [Medline]
  46. Neurum. URL: https://www.neurumhealth.com [Accessed 2025-07-12]
  47. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. May 2007;39(2):175-191. [CrossRef] [Medline]
  48. Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. Mar 1995;33(3):335-343. [CrossRef] [Medline]
  49. Wang K, Shi HS, Geng FL, et al. Cross-cultural validation of the Depression Anxiety Stress Scale-21 in China. Psychol Assess. May 2016;28(5):e88-e100. [CrossRef] [Medline]
  50. Colombo D, Fernández-Álvarez J, Patané A, et al. Current state and future directions of technology-based ecological momentary assessment and intervention for major depressive disorder: a systematic review. J Clin Med. Apr 5, 2019;8(4):465. [CrossRef] [Medline]
  51. Huckvale K, Venkatesh S, Christensen H. Toward clinical digital phenotyping: a timely opportunity to consider purpose, quality, and safety. NPJ Digit Med. 2019;2(1):88. [CrossRef] [Medline]
  52. Cuijpers P, Quero S, Noma H, et al. Psychotherapies for depression: a network meta-analysis covering efficacy, acceptability and long-term outcomes of all main treatment types. World Psychiatry. Jun 2021;20(2):283-293. [CrossRef] [Medline]
  53. Alkhwaiter B, Aloud M, Almezeini N. User experience in mHealth research: bibliometric analysis of trends and developments (2007-2023). JMIR mHealth uHealth. Nov 10, 2025;13(1):e75909. [CrossRef] [Medline]
  54. Carpenter JK, Andrews LA, Witcraft SM, Powers MB, Smits JAJ, Hofmann SG. Cognitive behavioral therapy for anxiety and related disorders: a meta-analysis of randomized placebo-controlled trials. Depress Anxiety. Jun 2018;35(6):502-514. [CrossRef] [Medline]
  55. Fernandez E, Salem D, Swift JK, Ramtahal N. Meta-analysis of dropout from cognitive behavioral therapy: magnitude, timing, and moderators. J Consult Clin Psychol. Dec 2015;83(6):1108-1122. [CrossRef] [Medline]
  56. Lam SU, Kirvin-Quamme A, Goldberg SB. Overall and differential attrition in mindfulness-based interventions: a meta-analysis. Mindfulness (N Y). Nov 2022;13(11):2676-2690. [CrossRef] [Medline]
  57. Barrett MS, Chua WJ, Crits-Christoph P, Gibbons MB, Casiano D, Thompson D. Early withdrawal from mental health treatment: implications for psychotherapy practice. Psychotherapy (Chic). Jun 1, 2008;45(2):247-267. [CrossRef] [Medline]
  58. Graham CD, McCracken LM, Harrison A, Walburn J, Weinman J. Outlining an acceptance and commitment therapy approach to treatment non-adherence. Br J Health Psychol. Feb 2022;27(1):1-12. [CrossRef] [Medline]
  59. Yin H, Zhu H, Gu J, et al. Mobile-based ecological momentary assessment and intervention: bibliometric analysis. Front Psychiatry. 2024;15:1300739. [CrossRef] [Medline]
  60. Yim SJ, Lui LMW, Lee Y, et al. The utility of smartphone-based, ecological momentary assessment for depressive symptoms. J Affect Disord. Sep 1, 2020;274:602-609. [CrossRef] [Medline]
  61. Hung YY, Huang KW, Kang HY, Huang GYL, Huang TL. Antidepressants normalize elevated Toll-like receptor profile in major depressive disorder. Psychopharmacology (Berl). May 2016;233(9):1707-1714. [CrossRef] [Medline]
  62. Rabbi M, Aung MH, Zhang M, Choudhury T. MyBehavior: automatic personalized health feedback from user behaviors and preferences using smartphones. Presented at: UbiComp ’15: Proceedings of the 2015 ACM International Joint Conference on Pervasive and Ubiquitous Computing; Sep 7-11, 2015. [CrossRef]
  63. Shang J, Wei S, Jin J, Zhang P. Mental health apps in China: analysis and quality assessment. JMIR mHealth uHealth. Nov 7, 2019;7(11):e13236. [CrossRef] [Medline]
  64. Linardon J, Messer M, Goldberg SB, Fuller-Tyszkiewicz M. The efficacy of mindfulness apps on symptoms of depression and anxiety: an updated meta-analysis of randomized controlled trials. Clin Psychol Rev. Feb 2024;107:102370. [CrossRef] [Medline]
  65. Huberty J, Green J, Glissmann C, Larkey L, Puzia M, Lee C. Efficacy of the mindfulness meditation mobile app “Calm” to reduce stress among college students: randomized controlled trial. JMIR Mhealth Uhealth. Jun 25, 2019;7(6):e14273. [CrossRef] [Medline]
  66. Flett JAM, Hayne H, Riordan BC, Thompson LM, Conner TS. Mobile mindfulness meditation: a randomised controlled trial of the effect of two popular apps on mental health. Mindfulness (N Y). May 2019;10(5):863-876. [CrossRef]
  67. de Manincor M, Bensoussan A, Smith CA, et al. Individualized yoga for reducing depression and anxiety, and improving well-being: a randomized controlled trial. Depress Anxiety. Sep 2016;33(9):816-828. [CrossRef] [Medline]
  68. State council measures to enhance people’s fitness, health. The State Council of the People’s Republic of China. 2019. URL: http://english.gov.cn/policies/latest_releases/2019/07/15/content_281476765851704.htm [Accessed 2025-07-12]
  69. HealthyLifestyle4All (2021–2023). European Commission. URL: https://sport.ec.europa.eu/healthylifestyle4all [Accessed 2025-07-12]
  70. Healthy people 2030. US Department of Health and Human Services. URL: https://odphp.health.gov/healthypeople [Accessed 2025-07-12]
  71. Healthy active learning. Ministry of Education (New Zealand). URL: https://sportnz.org.nz/healthy-active-learning/healthy-active-learning [Accessed 2025-07-12]
  72. Gopalkrishnan N. Cultural diversity and mental health: considerations for policy and practice. Front Public Health. 2018;6:179. [CrossRef] [Medline]
  73. Furnham A, Swami V. Mental health literacy: a review of what it is and why it matters. Int Perspect Psychol. Oct 2018;7(4):240-257. [CrossRef]
  74. Mak WW, Tong AC, Yip SY, et al. Efficacy and moderation of mobile app-based programs for mindfulness-based training, self-compassion training, and cognitive behavioral psychoeducation on mental health: randomized controlled noninferiority trial. JMIR Ment Health. Oct 11, 2018;5(4):e60. [CrossRef] [Medline]
  75. Dugas M, Gao GG, Agarwal R. Unpacking mHealth interventions: a systematic review of behavior change techniques used in randomized controlled trials assessing mHealth effectiveness. Digit Health. 2020;6:2055207620905411. [CrossRef] [Medline]
  76. Alexopoulos GS, Kiosses DN, Sirey JA, et al. Untangling therapeutic ingredients of a personalized intervention for patients with depression and severe COPD. Am J Geriatr Psychiatry. Nov 2014;22(11):1316-1324. [CrossRef] [Medline]
  77. Bewick BM, Trusler K, Barkham M, Hill AJ, Cahill J, Mulhern B. The effectiveness of web-based interventions designed to decrease alcohol consumption--a systematic review. Prev Med. Jul 2008;47(1):17-26. [CrossRef] [Medline]
  78. Martin R, Sunley P, Gardiner B, Tyler P. How regions react to recessions: resilience and the role of economic structure. Reg Stud. Apr 2, 2016;50(4):561-585. [CrossRef]


CONSORT-EHEALTH: Consolidated Standards of Reporting Trials of Electronic and Mobile Health Applications and Online Telehealth
DASS-21: Depression, Anxiety, and Stress Scale-21 items
EMA: ecological momentary assessment
EMI: ecological momentary intervention
MD: mean difference
mHealth: mobile health
RCT: randomized controlled trial


Edited by Alicia Stone, Lorraine Buis; submitted 10.Feb.2025; peer-reviewed by Lene Aasdahl, Soumyashree Sahoo; final revised version received 15.Dec.2025; accepted 15.Dec.2025; published 08.Sep.2026.

Copyright

© Sisi Li, Lik Hang Lincoln Lo, Chiu Yi Charlie Lau, Megan Lam, Meanne Chan. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org), 8.Sep.2026.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mHealth and uHealth, is properly cited. The complete bibliographic information, a link to the original publication on https://mhealth.jmir.org/, as well as this copyright and license information must be included.